dm+d

40232005

Articles

Safety in Lactation: Vaginal and vulval infections

23 September 2020Fungal vulval infections are normally associated with a vaginal infection which should be treated with an appropriate intravaginal cream or pessary – imidazole drugs to…

Safety in Lactation: Antifungal skin preparations

21 September 2020Topical preparations for fungal infections are considered to pose a negligible risk to a breastfeeding infant as long as precautions are taken to minimise contact…

Safety in Lactation: Preparations for scalp and hair conditions

18 September 2020Shampoos, topical eflornithine (for hirsutism) and minoxidil (for alopecia) are considered to pose a negligible risk to a breastfeeding infant. There is no published evidence…
Search Articles

Medicine Compliance Aid Stability

NizoralJanssen-Cilag Ltd

Janssen-Cilag Ltd
Nizoral
Tablets 200mg
A3 · Amber 3No stability data is available. There are theoretical concerns with use in CAs, which may be mitigated by risk minimisation.
Airtight container
Protect from moisture
Protect from moisture in an airtight container.
19 November 2015

Lactation Safety Information

Oral

Oral
Fluconazole
Limited published evidence of safety
Small amounts in breast milk
Unlikely to be absorbed by infant’s GI tract
Monitor infant for gastro-intestinal disturbances, especially if used for prolonged periods or in high doses, although unlikely to occur.
10 November 2020

For vaginal infections

For vaginal infections
Yes
17 September 2020

As a shampoo

As a shampoo
Yes
21 June 2021

For topical use

For topical use
Yes
21 June 2021